Advancing Research and Outcome Measurements of Parkinson's Disease Research

May 24, 2023

20 likes | 29 Views

Parkinson's disease is a complex condition with symptoms that can fluctuate over time. To know about the outcome measurements of Parkinson's disease, explore the blog now!

Share Presentation

Embed Code

Link

clinical5

Download Presentation

Advancing Research and Outcome Measurements of Parkinson's Disease Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Parkinson´s Disease

Parkinson´s Disease. Pekka Jäkälä, M.D., Ph.D. Department of Neuroscience and Neurology University and University Hospital of Kuopio, Finland. Outline:. Part A: Summary of Parkinson´s disease Part B: Molecular biology of Parkinson´s disease . PART A: Summary of Parkinson´s disease

907 views • 29 slides

Parkinson s Disease

Introduction. Progressive condition1:500 whole population1:50 of elderly1:10 Nursing Home Residents. Recognition. SlownessStiffnessTremorLoss of balance. First Diagnosis. PCT prioritiescarer supportmanage co-morbiditynursing needs assessmentPatient concernsdriving (DVLA, insurers)inherit

560 views • 23 slides

Drug treatment of Parkinson s disease

PARKINSON ?S DISEASE. (parkinsonism) is a neurodegenerative disorder which affects t h e b a s a l g a n g l i a - and is associated with a loss of dopaminergic neurons in the substantia nigra and degeneration of nerve terminals in

445 views • 20 slides

Results from Open Sky ’ s Outcome Research

Results from Open Sky ’ s Outcome Research. Joanna Bettmann, Ph.D, LCSW Open Sky Wilderness Therapy December, 2009. Outline of the Presentation. Why do research? Defining wilderness therapy Existing outcome research into wilderness therapy

595 views • 43 slides

Parkinson s disease

outline. History and DefinitionEpidemiology Aetiology Clinical featuresManagement Conclusion . Introduction . In 1817, James Parkinson, a physician in Hoxton, London, published The Shaking Palsy.Descibed it as paralysis agitansA degenerative disease with insidious onset, characterized by sl

679 views • 30 slides

PARKINSON S DISEASE

483 views • 25 slides

Treatment of Parkinson s Disease

Parkinson's Disease Overview. Prevalence: 0.3% of U.S. PopulationIncreases to 4-5% for those 85 years old and olderDopaminergic degeneration in the substantia nigrain the deep gray matter of the brainBasal ganglia produce less dopamine. Parkinson's Overview (cont'd). Symptoms:Bradykinesia (slo

394 views • 19 slides

Parkinson s Disease Genetics

In 1817, Dr. James Parkinson published the first widely acknowledged description of Parkinson's disease: An essay on the shaking palsy.". PD is a chronic, progressive neurodegenerative disorder. PD afflicts 1.5 million people in North America, and over 4 million worldwide. PD is primarily a

470 views • 27 slides

Research: Design and Outcome

Research: Design and Outcome. Lecture Preview. Research Methods and Designs Cross-Sectional and Longitudinal Designs Treatment Outcome Research Questions and Challenges in Conducting Treatment Outcome Research Contemporary Issues in Clinical Psychology Treatment Outcome Research

1.47k views • 97 slides

Parkinson ’ s disease

Parkinson ’ s disease. דר' דורון מרימס המרכז הגריאטרי שהם . Parkinson ’ s disease. Resting tremor Rigidity Bradykinesia Postural reflex impairment. Epidemiology. Begins between age 40-70 Peak age – sixth decade M:F 3:2 1% of the population over age 65.  -Synuclein and Lewy bodies.

975 views • 61 slides

Parkinson disease

Parkinson disease. Parkinson’s disease. Parkinson’s disease results from the degeneration of dopaminergic neurons in the substantia nigra These neurons project to other structures in the basal ganglia The basal ganglia includes the striatum, substantia nigra, globus pallidus and subthalmus.

1.26k views • 66 slides

The PARticulars of Parkinson ’ s Disease

Presented by: Cheryl A. Siefert, MNM Executive Director. The PARticulars of Parkinson ’ s Disease. Shaking Palsy. James Parkinson described “ Shaking Palsy ” in 1817. Progressive neurodegenerative disease Degeneration of dopamine neurons. Parkinson ’ s Disease. Dopamine.

347 views • 22 slides

RESEARCH EDUCATION OUTCOME AND CAPABILITIES

RESEARCH EDUCATION OUTCOME AND CAPABILITIES. Results of groupwork , point 5 on the agenda. Capabilities of a PhD Graduate (gr 1). To attract competitive research funding Ability to supervise research project (PI) Ability to publish in peer reviewed journals

224 views • 11 slides

Disease Research

Disease Research . The List…. Aids/HIV Alzheimers Amoebic Dysentery Anthrax Asthma Breast Cancer Broncitis Chicken Pox Cholera Cold Cystic Fibrosis Diabetes Diptheria Ebola Hansen’s Disease Hepatitis (A, B or C) Influenza Leukemia Lung Cancer Lyme Disease Malaria

244 views • 5 slides

Parkinson ’ s

Parkinson ’ s. A Review and Practical Guide to a Common and Complex Disease. Financial Disclosure. Still paying off school loans. No one has offered to help. If you work in industry and would like a shill, call me!.

763 views • 42 slides

Drug treatment of Parkinson ´s disease

Drug treatment of Parkinson ´s disease. Prof. MUDr Jiřina Martínková, CSc 2006/2007. PARKINSON ´S DISEASE. ( parkinsonism) is a neurodegenerative disorder which affects t h e b a s a l g a n g l i a - and is associated with a loss of dopaminergic neurons

444 views • 20 slides

Advancing GIS Education Research

http://edgis.org/research. Advancing GIS Education Research. Thomas R. Baker, Ph.D. ESRI Education Team http://edcommunity.esri.com/research. Advancing GIS Ed Research. http://edgis.org/research. What is GIS Education Research?

188 views • 6 slides

Cyber Advancing Research … Research Advancing Cyber

Cyber Advancing Research … Research Advancing Cyber. Scott F. Midkiff  : smidkiff@nsf.gov  : 703-292-8339 National Science Foundation Directorate for Engineering Electrical, Communications and Cyber Systems Division. Cyber Systems. “Cyber” implies the integration of… Computation,

358 views • 16 slides

Parkinson Disease

Parkinson Disease. A neurology primer. Background. Idiopathic Parkinson Disease (also referred to as primary or classical Parkinson disease) is a progressive neurodegenerative disorder associated with decrease dopamine in parts of the brain (nigrostriatal neurons). Background.

910 views • 44 slides

PARKINSON DISEASE

PARKINSON DISEASE. Is it a neurodegenerative brain disorder that progresses slowly in most people. Normally there are brain cells in the human brain that produce dopamine, these neurons concentrate in the substancia negra.

397 views • 16 slides

Parkinson Disease

Parkinson Disease. 03/27/2014. By: Marlene Rhodes Amna Alramadhani Madona Guirgis. Spontaneous motor impulses is an essential facet of control linked to frontal-basal ganglia circuitry. Basal ganglia dysfunction caused by Parkinson’s disease disrupts proficiency. Sings and Symptoms:.

678 views • 25 slides

Treatment of Parkinson Disease

Treatment of Parkinson Disease. David Tran, 2013 Mercer University PharmD Candidate. Epidemiology. Second to Alzheimer disease as the most common neurodegenerative disorder Men affected more than women Peak onset between 55 and 65 years Occurs in 1% to 2% of individuals older than 60 years

586 views • 13 slides

More Related